Jia-Horng Kao (Jia H Kao, J H Kao, J-H Kao)

Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 92

Top Venues

Alimentary pharmacology & therapeutics

Hepatology international

Liver international : official journal of the International Association for the Study of the Liver

Journal of gastroenterology and hepatology

American Association for the Study of Liver Diseases, AASLD

National Taiwan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

American Association for the Study of Liver Diseases, AASLD

United States

Academician

Education History

National Taiwan University

Taiwan

PHD :: Graduate Institute of Clinical Medicine, College of Medicine

Publications

Chiuan-Bo Huang, Tung-Hung Su, Jia-Horng Kao
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Shang-Chin Huang, Jia-Horng Kao
The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review. The Kaohsiung journal of medical sciences (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Chiuan-Bo Huang, Tung-Hung Su, Jia-Horng Kao
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Chi-Ling Chen, Tai-Chung Tseng, Chun-Jen Liu, Jia-Horng Kao, Pei-Jer Chen, Wei-Shiung Yang
Serum RNase-L Levels in Patients with Chronic Hepatitis B Virus Infection. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Chiuan-Bo Huang, Tung-Hung Su, Jia-Horng Kao
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Chiuan-Bo Huang, Tung-Hung Su, Jia-Horng Kao
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver (2023)
Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, Chi-Yi Chen, Ching-Chu Lo, Kuo-Chih Tseng, Pei-Yuan Su, Wei-Yu Kao, Ming-Chang Tsai, Hung-Da Tung, Hao-Tsai Cheng, Fu-Jen Lee, Chia-Sheng Huang, Ke-Jhang Huang, Yu-Lueng Shih, Sheng-Shun Yang, Jo-Hsuan Wu, Hsueh-Chou Lai, Yu-Jen Fang, Po-Yueh Chen, Jow-Jyh Hwang, Chi-Wei Tseng, Wei-Wen Su, Chun-Chao Chang, Pei-Lun Lee, Jyh-Jou Chen, Chi-Yang Chang, Tsai-Yuan Hsieh, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan. Hepatology international (2023)
Tung-Hung Su, Shan-Han Chang, Chi-Ling Chen, Sih-Han Liao, Tai-Chung Tseng, Shih-Jer Hsu, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Serial increase and high alpha-fetoprotein levels predict the risk of hepatocellular carcinoma in 6 months. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chi-Ling Chen, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Ting-Yuan Lan, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B. Hepatology international (2023)
Tai-Chung Tseng, Tetsuya Hosaka, Jia-Horng Kao
Response to Singh et al. The American journal of gastroenterology 118 (1) (2023)
Chiuan-Bo Huang, Tung-Hung Su, Jia-Horng Kao
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Chen-Hua Liu, Yu-Jen Fang, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. Journal of clinical medicine 12 (5) (2023)
Yen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, Pin-Nan Cheng, Ching-Chu Lo, Lein-Ray Mo, Chun-Ting Chen, Chung-Feng Huang, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Chi-Yi Chen, Kuo-Chih Tseng, Ming-Lung Yu, null On Behalf Of Tacr Investigators
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals. Viruses 14 (2) (2022)
Chih-Lin Lin, Jia-Horng Kao
Letter: vaccination for global control of hepatitis B-from prevention to elimination. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
Chen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng, Szu-Min Hsieh, Sheng-Shun Yang, Wei-Yu Kao, Yu-Lueng Shih, Chih-Lin Lin, Chun-Jen Liu, Wang-Huei Sheng, Yi-Chun Lo, Wen-Chun Liu, Jo-Hsuan Wu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Chien-Ching Hung, Jia-Horng Kao
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open forum infectious diseases 9 (8) (2022)
Tai-Chung Tseng, Jer-Wei Wu, Jia-Horng Kao
Looking Into the Crystal Ball: A Novel Biomarker for Outcomes of Patients With Chronic Hepatitis B Virus Infection. Hepatology communications 6 (1) (2022)
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection. Diagnostics (Basel, Switzerland) 12 (11) (2022)
Shang-Chin Huang, Jia-Horng Kao
Letter: hepatic steatosis and fibrosis in chronic hepatitis B-the chicken-and-egg conundrum. Alimentary pharmacology & therapeutics 55 (1) (2022)
Young-Suk Lim, Wai Kay Seto, Masayuki Kurosaki, Scott Fung, Jia-Horng Kao, Jinlin Hou, Stuart C Gordon, John F Flaherty, Leland J Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data. Alimentary pharmacology & therapeutics 55 (8) (2022)
Chih-Lin Lin, Chi-Ming Tai, Jee-Fu Huang, Chun-Jen Liu, Hui-Fen Chen, Pin-Nan Cheng, Chi-Yi Chen, Cheng-Yuan Peng, Chia-Chi Wang, Shih-Han Weng, Tai-Chung Tseng, Jia-Horng Kao
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan. Journal of gastroenterology and hepatology 37 (10) (2022)
Yu Jun Wong, R Kumar, Rahul Kumar, J Tan, C H Liu, Vw-K Hui, S S Tan, Jia-Horng Kao, Gl-H Wong, P H Thurairajah
Treatment outcomes of sofosbuvir/velpatasvir/voxilaprevir among NS5A inhibitor-experienced patients with hepatitis C: Real-world data from a multicenter Asian registry. Journal of gastroenterology and hepatology 37 (8) (2022)
Chen-Hua Liu, Jia-Horng Kao
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5. Hepatology international 16 (5) (2022)
Chih-Horng Wu, Jia-Horng Kao
Response to "Iodized Oil CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Within Milan Criteria". Hepatology international 16 (1) (2022)
Chen-Hua Liu, Jia-Horng Kao
Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Tai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, Fumitaka Suzuki, Chun-Ming Hong, Hiromitsu Kumada, Wan-Ting Yang, Chen-Yang Hsu, Tung-Hung Su, Hung-Chih Yang, Chen-Hua Liu, Pei-Jer Chen, Hsiu-Hsi Chen, Jia-Horng Kao
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase. The American journal of gastroenterology 117 (5) (2022)
Yung-Tsung Li, Chun-Jen Liu, Jia-Horng Kao, Li-Feng Lin, Hui-Chu Tu, Chih-Chiang Wang, Po-Hsi Huang, Huei-Ru Cheng, Pei-Jer Chen, Ding-Shinn Chen, Hui-Lin Wu
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function. Hepatology (Baltimore, Md.) (2022)
Chih-Horng Wu, Po-Chin Liang, Tung-Hung Su, Ming-Chi Lin, Yu-Hsuan Chang, Tiffany Ting-Fang Shih, Jia-Horng Kao
Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma. Hepatology international 15 (5) (2021)
Tai-Chung Tseng, Jonggi Choi, Mindie H Nguyen, Cheng-Yuan Peng, Spyros Siakavellas, George Papatheodoridis, Chia-Chi Wang, Young-Suk Lim, Hsueh-Chou Lai, Huy N Trinh, Christopher Wong, Clifford Wong, Jian Zhang, Jiayi Li, Jia-Horng Kao
One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. Hepatology international 15 (1) (2021)
Chen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, Ching-Chu Lo, Wei-Wen Su, Kuo-Chih Tseng, Chun-Jen Liu, Chia-Sheng Huang, Ke-Jhang Huang, Sheng-Shun Yang, Cheng-Yuan Peng, Ming-Chang Tsai, Wei-Yu Kao, Chi-Yang Chang, Yu-Lueng Shih, Yu-Jen Fang, Chi-Yi Chen, Pei-Lun Lee, Jow-Jyh Huang, Pei-Yuan Su, Chi-Wei Tseng, Chien-Ching Hung, Chung-Hsin Chang, Yi-Jie Huang, Hsueh-Chou Lai, Chun-Chao Chang, Fu-Jen Lee, Tsai-Yuan Hsieh, Jia-Horng Kao
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan. Hepatology international 15 (2) (2021)
Tung-Hung Su, Chih-Horng Wu, Jia-Horng Kao
Artificial intelligence in precision medicine in hepatology. Journal of gastroenterology and hepatology 36 (3) (2021)
Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, Ming-Lung Yu, Pei-Jer Chen
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses 13 (11) (2021)
Shang-Chin Huang, Sih-Han Liao, Tung-Hung Su, Yung-Ming Jeng, Jia-Horng Kao
Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma. Hepatology international 15 (2) (2021)
Chi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Ching-Chu Lo, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Ming-Lung Yu
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Huei-Ru Cheng, Hung-Chih Yang, Su-Ru Lin, Ta-Yu Yang, You-Yu Lin, Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Jia-Horng Kao
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients. Hepatology international 15 (3) (2021)
Meng-Hsuan Hsieh, Ming-Jong Bair, Pei-Chien Tsai, Kuo-Chih Tseng, Ching-Chu Lo, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, null null
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. Journal of gastroenterology and hepatology 36 (8) (2021)
Tai-Chung Tseng, Chun-Jen Liu, Wan-Ting Yang, Chen-Yang Hsu, Chun-Ming Hong, Tung-Hung Su, Cheng-Hsueh Tsai, Chi-Ling Chen, Hung-Chih Yang, Chen-Hua Liu, Hsiu-Hsi Chen, Pei-Jer Chen, Jia-Horng Kao
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary pharmacology & therapeutics 53 (8) (2021)
Yao-Chun Hsu, Cheng-Hao Tseng, Tung-Hung Su, Jia-Horng Kao, Mindie H Nguyen
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. Gut (2021)
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Kuo-Chih Tseng, Ching-Chu Lo, Chun-Jen Liu, Jyh-Jou Chen, Cheng-Yuan Peng, Yu-Lueng Shih, Sheng-Shun Yang, Chia-Sheng Huang, Ke-Jhang Huang, Chi-Yang Chang, Ming-Chang Tsai, Wei-Yu Kao, Yo-Jen Fang, Po-Yueh Chen, Pei-Yuan Su, Chih-Wei Tseng, Jow-Jyh Huang, Pei-Lun Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chung-Hsin Chang, Yi-Jie Huang, Fu-Jen Lee, Chun-Chao Chang, Jia-Horng Kao
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment. Gut 71 (1) (2021)
Chen-Hua Liu, Hsin-Yun Sun, Szu-Min Hsieh, Wen-Chun Liu, Wang-Hui Sheng, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Chien-Ching Hung, Jia-Horng Kao
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy. Journal of viral hepatitis 28 (6) (2021)
Margarita Papatheodoridi, Tung-Hung Su, Emilia Hadziyannis, Chun-Hsun Liao, Αfroditi Orfanidou, Hung-Chi Yang, Kalliopi Zachou, Chun-Jen Liu, Anastasia Kourikou, Nikolaos Gatselis, Spilios Manolakopoulos, Georgios N Dalekos, Jia-Horng Kao, Stephanos Hadziyannis, Georgios Papatheodoridis
ssHepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicenter cohort study. Liver international : official journal of the International Association for the Study of the Liver (2021)
Jia-Horng Kao, Wen-Juei Jeng, Qin Ning, Tung-Hung Su, Tai-Chung Tseng, Yoshiyuki Ueno, Man-Fung Yuen
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients. Hepatology international 15 (4) (2021)
Tung-Hung Su, Jia-Horng Kao
Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen-Negative Patients: An Asian Perspective. Clinical liver disease 16 (6) (2021)
Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Ron-Nan Chien, Chun-Yen Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Cheng-Yuan Peng
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort). Journal of gastroenterology and hepatology 36 (10) (2021)
Tai-Chung Tseng, Jia-Horng Kao
Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection-authors' reply. Alimentary pharmacology & therapeutics 53 (1) (2021)
Tung-Hung Su, Shih-Jer Hsu, Jia-Horng Kao
Paradigm shift in the treatment options of hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver (2021)
Jer-Wei Wu, Tai-Chung Tseng, Jia-Horng Kao
Letter to the Editor: New kid in the playground: HBcrAg and risk of HCC. Hepatology (Baltimore, Md.) (2021)
Chen-Hua Liu, Jia-Horng Kao
Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (7) (2021)
Shang-Chin Huang, Hau-Jyun Su, Jia-Horng Kao, Tai-Chung Tseng, Hung-Chih Yang, Tung-Hung Su, Pei-Jer Chen, Chun-Jen Liu
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease. Gut and liver 15 (3) (2021)
Chen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, Sheng-Shun Yang, Yu-Lueng Shih, Chin-Lin Lin, Meng-Kun Tsai, Chih-Yuan Lee, Chun-Chao Chang, Jo-Hsuan Wu, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment. Alimentary pharmacology & therapeutics (2021)
Chen-Hua Liu, Cheng-Yuan Peng, Yu-Jen Fang, Wei-Yu Kao, Sheng-Shun Yang, Cheng-Kuan Lin, Hsueh-Chou Lai, Wen-Pang Su, Sheng-Uei Fang, Chun-Chao Chang, Tung-Hung Su, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific reports 10 (1) (2020)
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, Hsueh-Chou Lai, Hsing-Tao Kuo, Chao-Hung Hung, Shui-Yi Tung, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Yung-Chang Lin, Chi-Chieh Yang, Gin-Ho Lo, Chi-Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Pei-Chien Tsai, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Cheng-Yuan Peng
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis. Scientific reports 10 (1) (2020)
Jia-Horng Kao, Tsung-Hui Hu, Ji-Dong Jia, Masayuki Kurosaki, Young Suk Lim, Han-Chieh Lin, Dong Hyun Sinn, Yasuhito Tanaka, Vincent Wai-Sun Wong, Man Fung Yuen
East Asia expert opinion on treatment initiation for chronic hepatitis B. Alimentary pharmacology & therapeutics 52 (10) (2020)
Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Shih-Wan Chou, Chen-Hua Liu, Hung-Chih Yang, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen, Jia-Horng Kao
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer. International journal of cancer 147 (3) (2020)
Chen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, Woan-Tyy Lin, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment. Journal of viral hepatitis 27 (6) (2020)
Pei-Jer Chen, Jia-Horng Kao, Chun-Jen Liu, Hung-Chih Yang
In Memoriam: Dr. Ding-Shinn Chen, 1943-2020. Hepatology (Baltimore, Md.) 72 (5) (2020)
Tung-Hung Su, Chi-Ling Chen, Jia-Horng Kao
Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply. Alimentary pharmacology & therapeutics 51 (2) (2020)
Andrea L Cox, Manal H El-Sayed, Jia-Horng Kao, Jeffrey Victor Lazarus, Maud Lemoine, Anna S Lok, Fabien Zoulim
Progress towards elimination goals for viral hepatitis. Nature reviews. Gastroenterology & hepatology 17 (9) (2020)
Vincent Wai-Sun Wong, Jia-Horng Kao
Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection-Authors' reply. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Pei-Chien Tsai, Chi-Yi Chen, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi-Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Ming-Lun Yeh, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chung, Chiao-Li Khale Ke, Ming-Lung Yu
Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open forum infectious diseases 7 (10) (2020)
Chi-Ling Chen, Ming-Jeng Kuo, Amy Ming-Fang Yen, Wei-Shiung Yang, Jia-Horng Kao, Pei-Jer Chen, Hsiu-Hsi Chen
Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma. JNCI cancer spectrum 4 (5) (2020)
Chris Estes, Henry Lik Yuen Chan, Rong-Nan Chien, Wan-Long Chuang, James Yan-Yue Fung, George Boon-Bee Goh, Tsung-Hui Hu, Jee-Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia-Horng Kao, Jin-Woo Lee, Han-Chieh Lin, Kathryn Razavi-Shearer, Wai Kay Seto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Homie Razavi
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Chen-Hua Liu, Jia-Horng Kao
Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply. Alimentary pharmacology & therapeutics 50 (1) (2020)
Chen-Hua Liu, Jia-Horng Kao
Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply. Alimentary pharmacology & therapeutics 49 (1) (2019)
Lai Wei, Vedran Pavlovic, Aruna T Bansal, Xiaoping Chen, Graham R Foster, Hua He, Jia-Horng Kao, Pietro Lampertico, Yun-Fan Liaw, Adriana Motoc, Georgios Papatheodoridis, Teerha Piratvisuth, Robert Plesniak, Cynthia Wat
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B. Journal of viral hepatitis 26 (9) (2019)
Tung-Hung Su, Sih-Han Liao, Chun-Ming Hong, Chun-Jen Liu, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen, Xavier Adhoute, Marc Bourlière, Jia-Horng Kao
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging. Journal of gastroenterology and hepatology 34 (12) (2019)
Jia-Horng Kao, Thomas Berg
Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop? Gut 68 (12) (2019)
H-H Lin, Jia-Horng Kao, Y-L Huang, K-L Liu, Jia-Horng Kao
Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts. Journal of gastroenterology and hepatology 35 (1) (2019)
Tung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, Shih-Wan Chou, Chen-Hua Liu, Hung-Chih Yang, Shang-Ju Wu, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen, Jia-Horng Kao
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Alimentary pharmacology & therapeutics 49 (5) (2019)
Chen-Hua Liu, Jia-Horng Kao
Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction? Alimentary pharmacology & therapeutics 49 (2) (2019)
Chen-Hua Liu, Yu-Lueng Shih, Sheng-Shun Yang, Chih-Lin Lin, Yu-Jen Fang, Pin-Nan Cheng, Chi-Yi Chen, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yen-Cheng Chiu, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Journal of gastroenterology and hepatology 34 (11) (2019)
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao
Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary pharmacology & therapeutics 51 (2) (2019)
Chen-Hua Liu, Chun-Jen Liu, Chien-Ching Hung, Szu-Min Hsieh, Tung-Hung Su, Hsin-Yun Sun, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2019)
Chen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Chun-Ming Hong, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan. PloS one 13 (12) (2018)
Tung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, Shih-Wan Chou, Chen-Hua Liu, Hung-Chih Yang, Shang-Ju Wu, Pei-Jer Chen, Ding-Shinn Chen, Chi-Ling Chen, Jia-Horng Kao
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Alimentary pharmacology & therapeutics 49 (3) (2018)
Tung-Hung Su, Chun-Hsun Liao, Chen-Hua Liu, Kai-Wen Huang, Tai-Chung Tseng, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy. Radiology 288 (1) (2018)
C-L Lin, Jia-Horng Kao
Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Alimentary pharmacology & therapeutics 48 (1) (2018)
Chen-Hua Liu, H-Y Sun, Chun-Jen Liu, W-H Sheng, S-M Hsieh, Y-C Lo, W-C Liu, T-H Su, H-C Yang, C-M Hong, T-C Tseng, P-J Chen, D-S Chen, Chien-Ching Hung, Jia-Horng Kao
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. Alimentary pharmacology & therapeutics 47 (12) (2018)
Tai-Chung Tseng, Chun-Jen Liu, T-H Su, W-T Yang, C-L Chen, H-C Yang, S F-T Kuo, C-H Liu, P-J Chen, D-S Chen, Jia-Horng Kao
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection. Alimentary pharmacology & therapeutics 47 (11) (2018)
Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V Nguyen, Ching Lung Lai, Henry Lik Yuen Chan, Lai Wei
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection. Journal of viral hepatitis 25 (12) (2018)
Chen-Hua Liu, Yi-Jie Huang, Sien-Sing Yang, Chung-Hsin Chang, Sheng-Shun Yang, Hsin-Yun Sun, Chun-Jen Liu, Wen-Chun Liu, Tung-Hung Su, Hung-Chih Yang, Chun-Ming Hong, Tai-Chung Tseng, Pei-Jer Chen, Ding-Shinn Chen, Chien-Ching Hung, Jia-Horng Kao
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Scientific reports 8 (1) (2018)
Ming-Hung Hu, Tzu-Ting Huang, Tzu-I Chao, Li-Ju Chen, Yen-Lin Chen, Ming-Hsien Tsai, Chun-Yu Liu, Jia-Horng Kao, Kuen-Feng Chen
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver 38 (12) (2018)
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan. Alimentary pharmacology & therapeutics 48 (11-12) (2018)
Mei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, Yung-Chang Lin, Chia-Yen Dai, Chun-Jen Liu, Jing-Houng Wang, Jee-Fu Huang, Wen-Pang Su, Hung-Chih Yang, Kwong-Ming Kee, Ming-Lun Yeh, Po-Heng Chuang, Shih-Jer Hsu, Ching-I Huang, Jung-Ta Kao, Chieh-Chang Chen, Sheng-Hung Chen, Wen-Juei Jeng, Hwai-I Yang, Yong Yuan, Sheng-Nan Lu, I-Shyan Sheen, Chen-Hua Liu, Cheng-Yuan Peng, Jia-Horng Kao, Ming-Lung Yu, Wan-Long Chuang, Chien-Jen Chen
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients. Scientific reports 7 (1) (2017)
Tung-Hung Su, Chung-Wai Shiau, Ping Jao, Nian-Jie Yang, Wei-Tien Tai, Chun-Jen Liu, Tai-Chung Tseng, Hung-Chih Yang, Chen-Hua Liu, Kai-Wen Huang, Ting-Chen Hu, Yu-Jen Huang, Yao-Ming Wu, Li-Ju Chen, Pei-Jer Chen, Ding-Shinn Chen, Kuen-Feng Chen, Jia-Horng Kao
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis. Scientific reports 7 (1) (2017)
Tai-Chung Tseng, Jia-Horng Kao
Elimination of Hepatitis B: Is It a Mission Possible? BMC medicine 15 (1) (2017)
C-C Wang, Jia-Horng Kao
Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation. Alimentary pharmacology & therapeutics 46 (2) (2017)

Jia-Horng Kao.css-eqlu8i{font-size:small;padding-left:4px;} (Jia H Kao, J H Kao, J-H Kao)

Publication Activity (10 Years)

Top Topics

Top Venues

Jia-Horng Kao (Jia H Kao, J H Kao, J-H Kao)